Macitentan, a dual endothelin receptor antagonist, in combination with temozolomide leads to glioblastoma regression and long-term survival in mice

PURPOSE: The objective of the study was to determine whether astrocytes and brain endothelial cells protect glioma cells from temozolomide (TMZ) through an endothelin-dependent signaling mechanism and to examine the therapeutic efficacy of the dual endothelin receptor antagonist, macitentan, in orth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Kim, Sun-Jin, Lee, Ho Jeong, Kim, Mark Seungwook, Choi, Hyun Jin, He, Junqin, Wu, Qiuyu, Aldape, Kenneth, Weinberg, Jeffrey S., Alfred Yung, W. K., Conrad, Charles A., Langley, Robert R., Lehembre, François, Regenass, Urs, Fidler, Isaiah J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4780217/
https://ncbi.nlm.nih.gov/pubmed/26106074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-3195
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados